The frequency of adverse reactions to benznidazole is high when treating chronic Chagas patients, although the effects were mostly mild, according to a study led by ISGlobal, in collaboration with the Hospital Clinic of Barcelona. ...
Feb 21, 2018
0
8
In an Epilepsia analysis of 2008-2010 Medicare claims data, one in four older Americans with new-onset epilepsy and more than one-third with prevalent epilepsy received a combination of antiepileptic drugs and non-epilepsy ...
Feb 7, 2018
0
26
Carnegie Mellon University researchers have developed a new method for delivering chemotherapy nanodrugs that increases the drugs' bioavailability and reduces side-effects.
Nov 28, 2017
0
28
The liver is crucial for the detoxification of the human body. The exposure to toxins makes it particularly prone to drug-induced injury. Cholestasis, the impairment of bile flow, is therefore a common problem of drug development ...
Mar 27, 2017
0
26
Last summer, within eight hours, 12 patients were brought to the emergency department at Yale New Haven Hospital with signs of drug overdose. They had been exposed to toxic doses of fentanyl, a highly potent opioid 50 times ...
Feb 3, 2017
0
0
A panel of federal health advisers has narrowly recommended approval for an experimental antibiotic from Cempra Inc., a small North Carolina drugmaker.
Nov 4, 2016
0
1
Not a morning person? Neither are your kidneys. Research from the Washington State University College of Pharmacy suggests there may be benefits to timing chemotherapy in cancer patients to the time of day the body is "most ...
Jun 7, 2016
0
0
Formulating drugs as liquid salts may provide a safe and efficient strategy for topical delivery of drugs that cause skin toxicity. A team of researchers from the University of California, Santa Barbara (UCSB) in Santa Barbara, ...
Dec 29, 2015
0
8
In new research appearing in the prestigious journal Nature Biotechnology, an international research team led by The Hebrew University of Jerusalem describes a new technique for growing human hepatocytes in the laboratory. ...
Nov 26, 2015
0
553
A study, published online in Blood, the Journal of the American Society of Hematology (ASH), reports that bretuximab vedotin is an effective and safe first course of treatment for older Hodgkin lymphoma patients unfit for ...
Sep 21, 2015
0
7
